V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20207603 | 20077581 | 0 | 0 | Curative (C) | 2018-08-06 | 2018-08-20 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100900068 |
| 20207614 | 20077582 | 1.66 | 58 | Palliative (P) | 2016-05-08 | 2017-05-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101455131 |
| 20207615 | 20077583 | 0 | 0 | Palliative (P) | null | 2020-02-17 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100042920 |
| 20207616 | 20077584 | 1.8 | 82.5 | Palliative (P) | 2016-07-22 | 2016-07-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100970106 |
| 20207621 | 20077585 | 1.76 | 58.4 | Curative (C) | 2018-03-07 | 2018-03-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100319197 |
| 20207624 | 20077586 | 1.6 | 89 | Palliative (P) | 2019-07-29 | 2019-08-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100690331 |
| 20207627 | 20077587 | 1.76 | 59.25 | Neo-adjuvant (N) | 2019-12-26 | 2019-12-31 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100412073 |
| 20207633 | 20077588 | 1.7 | 79.8 | null | 2018-01-26 | 2018-02-14 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101468877 |
| 20207635 | 20077589 | 1.73 | 79.6 | 03 | 2018-05-01 | 2018-05-02 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100822228 |
| 20207636 | 20077590 | 1.75 | 44 | Palliative (P) | 2021-03-19 | 2021-03-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100522018 |
| 20207640 | 20077591 | 1.67 | 72.2 | Curative (C) | 2017-10-12 | 2017-10-14 | CISPLATIN + FLUOROURACIL | 2 | Y | CISPLATIN + FLUOROURACIL | 101132674 |
| 20207642 | 20077592 | 1.65 | 50.9 | Palliative (P) | 2018-05-12 | 2018-05-20 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100165283 |
| 20207644 | 20077593 | 1.5 | 96 | null | 2018-04-05 | 2018-04-22 | Cisplatin +Fluorouracil (3 wk) | N | null | CISPLATIN + FLUOROURACIL | 100463667 |
| 20207651 | 20077594 | 1.4 | 36.9 | Palliative (P) | 2018-12-11 | 2018-12-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101137388 |
| 20207654 | 20077595 | 1.56 | 52.4 | 03 | null | 2016-10-05 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101179225 |
| 20207668 | 20077596 | 1.69 | 59.2 | Curative (C) | null | 2019-07-15 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101108149 |
| 20207670 | 20077597 | 1.66 | 60 | Palliative (P) | 2016-02-21 | 2016-03-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101574405 |
| 20207675 | 20077598 | null | null | Palliative (P) | 2019-11-06 | 2019-12-06 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101810193 |
| 20207677 | 20077599 | 1.73 | null | Neo-adjuvant (N) | 2017-02-06 | 2017-02-26 | Capecitabine + Carboplatin + RT | N | N | TRIAL UNSPECIFIED | 100781179 |
| 20207681 | 20077600 | 1.7 | 67.5 | Neo-adjuvant (N) | 2017-12-12 | 2018-01-09 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101659606 |
| 20207683 | 20077601 | 0 | 0 | Curative (C) | 2017-03-14 | 2017-03-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100399108 |
| 20207686 | 20077602 | 1.85 | 66.6 | Neo-adjuvant (N) | 2018-05-23 | 2018-06-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101717484 |
| 20207689 | 20077603 | 1.78 | 77 | Palliative (P) | 2018-10-04 | 2018-10-04 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101251210 |
| 20207690 | 20077604 | 1.82 | 0 | Palliative (P) | 2016-09-30 | 2016-10-19 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100657876 |
| 20207697 | 20077605 | 1.72 | 100 | Palliative (P) | 2017-06-13 | 2017-06-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101520569 |
| 20207699 | 20077606 | 1.78 | 81.8 | Palliative (P) | 2017-12-18 | 2017-12-18 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100671215 |
| 20207701 | 20077607 | 1.8 | 43.9 | null | 2019-10-18 | 2019-10-18 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100005483 |
| 20207708 | 20077608 | 1.6 | 94.9 | null | 2016-05-03 | 2016-05-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100544969 |
| 20207710 | 20077609 | 1.69 | 119 | null | 2018-03-31 | 2018-04-07 | CAPECITABINE + CARBOPLATIN | N | null | TRIAL UNSPECIFIED | 100962805 |
| 20207711 | 20077610 | 0 | 0 | Neo-adjuvant (N) | 2018-03-03 | 2018-03-24 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101827312 |
| 20207720 | 20077611 | 1.61 | 67.55 | Palliative (P) | 2016-04-18 | 2016-04-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100069573 |
| 20207721 | 20077612 | 1.67 | 98 | Palliative (P) | 2016-11-01 | 2016-11-09 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100720109 |
| 20207723 | 20077613 | 0 | 0 | Palliative (P) | 2018-05-22 | 2018-05-22 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100306048 |
| 20207724 | 20077614 | 1.76 | 49.65 | Neo-adjuvant (N) | 1984-08-08 | 2019-04-07 | CISPLATIN + FLUOROURACIL | N | N | CAPECITABINE + CARBOPLATIN | 100010193 |
| 20207725 | 20077615 | 1.69 | 71.8 | Neo-adjuvant (N) | 2019-11-11 | 2019-11-16 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101545402 |
| 20207731 | 20077616 | 1.62 | 87.4 | Palliative (P) | 2019-12-08 | 2019-12-10 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101848245 |
| 20207734 | 20077617 | 1.54 | 101.6 | Curative (C) | 2019-06-19 | 2019-07-15 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101647618 |
| 20207736 | 20077618 | 0 | 0 | Neo-adjuvant (N) | 2017-06-09 | 2017-06-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101419523 |
| 20207740 | 20077619 | 0 | 0 | null | 2019-11-12 | 2019-12-02 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101490298 |
| 20207741 | 20077620 | 1.76 | 59 | Curative (C) | 2019-02-09 | 2019-02-27 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 100077122 |
| 20207744 | 20077621 | 0 | 0 | Curative (C) | null | 2019-05-22 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100050581 |
| 20207749 | 20077622 | 1.62 | 0 | Adjuvant (A) | 2020-02-18 | 2020-02-28 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100820359 |
| 20207756 | 20077623 | 1.79 | 82.35 | null | 2018-06-06 | 2018-06-20 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100342067 |
| 20207758 | 20077624 | 1.72 | 54.5 | Palliative (P) | 2018-01-21 | 2018-01-25 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100738308 |
| 20207759 | 20077625 | 0 | 0 | Curative (C) | 2019-10-15 | 2019-11-11 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101122771 |
| 20207760 | 20077626 | 0 | 0 | Palliative (P) | 2016-10-07 | 2016-10-27 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100772963 |
| 20207763 | 20077627 | 1.52 | 52 | 03 | 2017-11-30 | 2017-12-07 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100482275 |
| 20207764 | 20077628 | 1.69 | 46.8 | Palliative (P) | 2019-02-15 | 2019-02-20 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101722982 |
| 20207771 | 20077629 | 1.63 | 51.1 | Neo-adjuvant (N) | 2019-08-28 | 2019-09-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100084456 |
| 20207772 | 20077630 | 1.57 | 63.3 | Palliative (P) | 2016-07-15 | 2016-07-26 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100614195 |